Navigating Controversies in Polygenic Embryo Screening – ESHRE
European Society of Human Reproduction and Embryology (ESHRE) shared a post on LinkedIn:
“Polygenic Embryo Screening: Where Do We Stand?
Polygenic embryo screening (PES) can now assessm IVF embryos for risks of heart disease, diabetes, schizophrenia and cancers. It’s already available, but highly controversial.
The disconnect: patients show strong interest – healthcare professionals have serious concerns.
Join this ESHRE webinar as international experts share new research on these diverging attitudes. Through focused presentations and panel discussion, we’ll explore:
- What drives patient demand vs. professional hesitation
- How views differ across cultures and demographics
- The implications for policy, education and patient care
Date: 10 February 2026 | 17:00 CET
Be part of shaping how we navigate this emerging frontier in Reproductive Genetics.
Find out more.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 14, 2026, 17:27Giulia Zamagni: Critical Gaps in Machine Learning Models for Fetal Growth Restriction
-
Jan 14, 2026, 17:25Structured Multidisciplinary Pathways for Endometriosis – Fondation Endométriose
-
Jan 14, 2026, 17:23Daniel Roshan: Maternal Nail Polish Use and Potential Fetal Exposure
-
Jan 14, 2026, 17:21Rethinking Soy for Women With Endometriosis – Fertility Plus
-
Jan 14, 2026, 17:19Leili Mohebnasab: Understanding Placental Health Through Epigenetics
-
Jan 14, 2026, 17:17High Estradiol and Placental Pathology in Fresh IVF Pregnancies – Fertility and Sterility
-
Jan 12, 2026, 16:03New Insights Into Estrogen Receptor Alpha Regulation in the Endometrium – Fertility and Sterility
-
Jan 12, 2026, 15:37From Innovation to Practice: Standards for Embryo Diagnostic Trials – Fertility and Sterility
-
Jan 12, 2026, 14:47HFEA Updates Choose a Fertility Clinic Tool to Improve Success Reporting